Changing the perception of early-phase cancer clinical trials - Cancer Currents Blog

The latest from the NCI Cancer Currents blog

Having trouble viewing this email? View it as a Web page.

Due to a technical issue, the subscriber email for this Cancer Currents story is being sent late. We apologize for any inconvenience. Changing the Perception of Early-Phase Cancer Clinical Trials: A Conversation with Dr. Naoko Takebe 11/10/2022 The number of participants in modern phase 1 cancer clinical trials whose cancer responded to the treatment or remained stable has increased substantially. At the same time, treatment-related deaths remained very low, a new NCI study shows. Dr. Naoko Takebe discusses the findings and the importance of phase 1 trials. You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892